Topics

NextGen advises "Trying to Manage".

08:00 EDT 4th October 2019 | BioPortfolio

Summary of "NextGen advises "Trying to Manage"."

No Summary Available

Affiliation

Journal Details

This article was published in the following journal.

Name: Science (New York, N.Y.)
ISSN: 1095-9203
Pages: 28-30

Links

DeepDyve research library

PubMed Articles [775 Associated PubMed Articles listed on BioPortfolio]

Receptor-binding affinities of bisphenol A and its next-generation analogs for human nuclear receptors.

An endocrine-disrupting chemical Bisphenol A (BPA) binds specifically to a nuclear receptor (NR) named ERRγ. Although the importance of receptor-binding evaluation for human NRs is often stressed, th...

NextGen Voices: Science-inspired sustainable behavior.

Intractable Epistaxis: Looking Beyond the Usual Sites.

Intractable epistaxis is a challenge to manage and often requires multiple interventions, both medical and surgical. After anterior and posterior packing, many options exist on how to manage the patie...

Cross-sectional study of the prevalence, causes and management of hospital-onset diarrhoea.

The National Health Service in England advises hospitals collect data on hospital-onset diarrhoea (HOD). Contemporaneous data on HOD are lacking.

Iranian pre-hospital emergency care nurses' strategies to manage workplace violence: A descriptive qualitative study.

To explore the experiences of Iranian nurses working in pre-hospital emergency care services and the strategies used to manage of workplace violence.

Clinical Trials [753 Associated Clinical Trials listed on BioPortfolio]

Safety Study of Subcutaneous Ig NextGen 16% in Patients With Primary Immunodeficiency

The study aims to assess the safety and tolerability of subcutaneous Ig NextGen 16% in patients with Primary Immune Deficiency who require Immunoglobulin (Ig) G replacement therapy. Ig Ne...

Subcutaneous Ig NextGen 16% in PID Patients

This study aims to assess the safety, tolerability, efficacy and pharmacokinetics of Ig NextGen 16% in people with antibody deficiency currently being treated with IntragamP. Ig NextGen 1...

Ig NextGen 10% in Idiopathic Thrombocytopenic Purpura (ITP) Patients

Idiopathic Thrombocytopenic Purpura (ITP) is an autoimmune bleeding disorder characterised by isolated low platelet counts. The aim of treating patients with ITP is to increase the platele...

Neurogenetics Patient Registry

The objective of this project is to develop a Neurogenetics patient database and bio repository - which includes clinical information regarding history, physical examination, laboratory te...

Empowering Patients to Better Manage Diabetes Through Self-Care

This study will look at the impact of health insurance benefits on self management of diabetes for people with this condition. Studies have shown that when people with diabetes manage the...

Medical and Biotech [MESH] Definitions

An ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKER that is used to manage HYPERTENSION.

Software designed to store, manipulate, manage, and control data for specific uses.

A STEROID with GLUCOCORTICOID RECEPTOR activity that is used to manage the symptoms of ASTHMA; ALLERGIC RHINITIS, and ATOPIC DERMATITIS.

An individual's ability to manage and monitor their emotions, behaviors, and desires in the face of external demands in order to function in society.

A quinoxaline derivative and ADRENERGIC ALHPA-2 RECEPTOR AGONIST that is used to manage INTRAOCULAR PRESSURE associated with OPEN-ANGLE GLAUCOMA and OCULAR HYPERTENSION.

Quick Search


DeepDyve research library

Searches Linking to this Article